US Stock MarketDetailed Quotes

EYPT EyePoint Pharmaceuticals

Watchlist
  • 8.460
  • -0.390-4.41%
Close Dec 10 16:00 ET
  • 8.460
  • 0.0000.00%
Post 20:01 ET
577.40MMarket Cap-4251P/E (TTM)

EyePoint Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-156.70%-39.03M
-135.39%-20.18M
-85.16%-31.17M
102.88%1.88M
-83.58%-23.11M
-15.74%-15.2M
398.19%57.02M
16.48%-16.84M
-29.76%-65.01M
24.48%-12.59M
Net income from continuing operations
-132.80%-29.36M
-34.49%-30.83M
-38.37%-29.28M
30.77%-70.8M
67.55%-14.1M
31.53%-12.61M
-18.11%-22.92M
-0.90%-21.16M
-75.04%-102.25M
-123.61%-43.45M
Operating gains losses
----
----
----
-13.60%1.35M
--0
--0
----
----
175.50%1.56M
--0
Depreciation and amortization
254.78%408K
174.24%362K
188.57%303K
-81.03%464K
-66.57%112K
-83.83%115K
-81.25%132K
-84.91%105K
-11.73%2.45M
-52.01%335K
Deferred tax
----
----
----
--83K
----
----
----
----
--0
----
Other non cash items
-4,710.26%-1.88M
-3,217.65%-1.69M
-135.66%-575K
-53.41%-856K
-53.53%-522K
81.78%-39K
55.26%-51K
-321.82%-244K
-188.85%-558K
-304.82%-340K
Change In working capital
-148.45%-15.65M
-95.68%3.28M
-1,109.45%-14.31M
2,047.80%58.88M
-352.53%-12.27M
-496.54%-6.3M
1,809.78%76.03M
128.22%1.42M
-73.84%-3.02M
322.32%4.86M
-Change in receivables
-108.74%-939K
415.83%3.09M
-186.37%-4.26M
642.15%14.43M
-104.28%-269K
2,820.65%10.75M
84.64%-979K
267.93%4.93M
74.89%-2.66M
205.00%6.28M
-Change in inventory
374.60%865K
180.66%584K
70.38%-351K
-104.34%-1.55M
179.41%671K
-13.72%-315K
-982.93%-724K
-523.21%-1.19M
-156.42%-760K
-245.69%-845K
-Change in payables and accrued expense
-109.00%-6.04M
-14.81%5.07M
36.92%-1.43M
26.79%1.52M
250.72%728K
-263.13%-2.89M
194.84%5.95M
-7.59%-2.27M
-85.87%1.2M
-114.02%-483K
-Change in other working capital
48.62%-7.11M
-107.60%-5.46M
-13,243.55%-8.27M
5,667.46%44.48M
-14,468.48%-13.4M
-4,951.46%-13.84M
41,597.11%71.79M
76.15%-62K
16.68%-799K
60.17%-92K
Cash from discontinued investing activities
Operating cash flow
-156.70%-39.03M
-135.39%-20.18M
-85.16%-31.17M
102.88%1.88M
-83.58%-23.11M
-15.74%-15.2M
398.19%57.02M
16.48%-16.84M
-29.76%-65.01M
24.48%-12.59M
Investing cash flow
Cash flow from continuing investing activities
1,041.63%16.2M
-1,291.02%-160.4M
-35.16%20.81M
80.80%-3.32M
-243.23%-47.15M
-127.42%-1.72M
112,325.00%13.47M
156.85%32.09M
47.87%-17.27M
199.85%32.92M
Net PPE purchase and sale
8.49%-1.57M
-127.27%-900K
-146.69%-1.19M
-62.00%-3.48M
-50.94%-883K
-43.57%-1.72M
-81.65%-396K
-224.83%-484K
-1,278.21%-2.15M
---585K
Net investment purchase and sale
--17.77M
-1,250.51%-159.5M
-32.45%22M
101.11%168K
-238.10%-46.27M
--0
6,629.61%13.86M
157.86%32.57M
54.15%-15.12M
201.63%33.5M
Cash from discontinued investing activities
Investing cash flow
1,041.63%16.2M
-1,291.02%-160.4M
-35.16%20.81M
80.80%-3.32M
-243.23%-47.15M
-127.42%-1.72M
112,325.00%13.47M
156.85%32.09M
47.87%-17.27M
199.85%32.92M
Financing cash flow
Cash flow from continuing financing activities
14.78%11.89M
100.90%329K
102.25%115K
27,211.59%187.07M
376,798.28%218.49M
11,163.04%10.36M
-13,181.88%-36.66M
-1,042.63%-5.12M
-100.32%-690K
-100.05%-58K
Net issuance payments of debt
---73K
--0
--0
-2,026.34%-40.51M
--0
--0
-103,761.76%-35.31M
-335.52%-5.2M
1,540.41%2.1M
22.73%-34K
Net common stock issuance
----
----
----
--226.17M
--216.2M
----
----
----
--0
--0
Proceeds from stock option exercised by employees
-68.74%251K
12,400.00%625K
1,738.71%4.56M
754.94%3.38M
--2.32M
421.43%803K
--5K
2.90%248K
5.90%395K
--0
Net other financing activities
81.20%-78K
78.07%-296K
-2,530.18%-4.45M
38.21%-1.97M
-50.00%-36K
-1,496.15%-415K
-457.85%-1.35M
94.16%-169K
-2,025.33%-3.19M
-380.00%-24K
Cash from discontinued financing activities
Financing cash flow
14.78%11.89M
100.90%329K
102.25%115K
27,211.59%187.07M
376,798.28%218.49M
11,163.04%10.36M
-13,181.88%-36.66M
-1,042.63%-5.12M
-100.32%-690K
-100.05%-58K
Net cash flow
Beginning cash position
-34.94%90.92M
156.02%271.16M
193.80%281.41M
-46.41%95.78M
76.38%133.19M
69.83%139.75M
4.15%105.92M
-46.41%95.78M
296.69%178.74M
-37.00%75.51M
Current changes in cash
-66.70%-10.94M
-632.76%-180.24M
-201.16%-10.25M
323.76%185.63M
631.23%148.23M
3.10%-6.56M
274.29%33.83M
113.15%10.13M
-162.06%-82.96M
-65.57%20.27M
End cash Position
-39.95%79.98M
-34.94%90.92M
156.02%271.16M
193.80%281.41M
193.80%281.41M
76.38%133.19M
69.83%139.75M
4.15%105.92M
-46.41%95.78M
-46.41%95.78M
Free cash flow
-139.91%-40.6M
-137.22%-21.08M
-86.88%-32.37M
97.61%-1.61M
-82.13%-23.99M
-18.07%-16.92M
392.78%56.63M
14.71%-17.32M
-33.63%-67.16M
20.97%-13.17M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -156.70%-39.03M-135.39%-20.18M-85.16%-31.17M102.88%1.88M-83.58%-23.11M-15.74%-15.2M398.19%57.02M16.48%-16.84M-29.76%-65.01M24.48%-12.59M
Net income from continuing operations -132.80%-29.36M-34.49%-30.83M-38.37%-29.28M30.77%-70.8M67.55%-14.1M31.53%-12.61M-18.11%-22.92M-0.90%-21.16M-75.04%-102.25M-123.61%-43.45M
Operating gains losses -------------13.60%1.35M--0--0--------175.50%1.56M--0
Depreciation and amortization 254.78%408K174.24%362K188.57%303K-81.03%464K-66.57%112K-83.83%115K-81.25%132K-84.91%105K-11.73%2.45M-52.01%335K
Deferred tax --------------83K------------------0----
Other non cash items -4,710.26%-1.88M-3,217.65%-1.69M-135.66%-575K-53.41%-856K-53.53%-522K81.78%-39K55.26%-51K-321.82%-244K-188.85%-558K-304.82%-340K
Change In working capital -148.45%-15.65M-95.68%3.28M-1,109.45%-14.31M2,047.80%58.88M-352.53%-12.27M-496.54%-6.3M1,809.78%76.03M128.22%1.42M-73.84%-3.02M322.32%4.86M
-Change in receivables -108.74%-939K415.83%3.09M-186.37%-4.26M642.15%14.43M-104.28%-269K2,820.65%10.75M84.64%-979K267.93%4.93M74.89%-2.66M205.00%6.28M
-Change in inventory 374.60%865K180.66%584K70.38%-351K-104.34%-1.55M179.41%671K-13.72%-315K-982.93%-724K-523.21%-1.19M-156.42%-760K-245.69%-845K
-Change in payables and accrued expense -109.00%-6.04M-14.81%5.07M36.92%-1.43M26.79%1.52M250.72%728K-263.13%-2.89M194.84%5.95M-7.59%-2.27M-85.87%1.2M-114.02%-483K
-Change in other working capital 48.62%-7.11M-107.60%-5.46M-13,243.55%-8.27M5,667.46%44.48M-14,468.48%-13.4M-4,951.46%-13.84M41,597.11%71.79M76.15%-62K16.68%-799K60.17%-92K
Cash from discontinued investing activities
Operating cash flow -156.70%-39.03M-135.39%-20.18M-85.16%-31.17M102.88%1.88M-83.58%-23.11M-15.74%-15.2M398.19%57.02M16.48%-16.84M-29.76%-65.01M24.48%-12.59M
Investing cash flow
Cash flow from continuing investing activities 1,041.63%16.2M-1,291.02%-160.4M-35.16%20.81M80.80%-3.32M-243.23%-47.15M-127.42%-1.72M112,325.00%13.47M156.85%32.09M47.87%-17.27M199.85%32.92M
Net PPE purchase and sale 8.49%-1.57M-127.27%-900K-146.69%-1.19M-62.00%-3.48M-50.94%-883K-43.57%-1.72M-81.65%-396K-224.83%-484K-1,278.21%-2.15M---585K
Net investment purchase and sale --17.77M-1,250.51%-159.5M-32.45%22M101.11%168K-238.10%-46.27M--06,629.61%13.86M157.86%32.57M54.15%-15.12M201.63%33.5M
Cash from discontinued investing activities
Investing cash flow 1,041.63%16.2M-1,291.02%-160.4M-35.16%20.81M80.80%-3.32M-243.23%-47.15M-127.42%-1.72M112,325.00%13.47M156.85%32.09M47.87%-17.27M199.85%32.92M
Financing cash flow
Cash flow from continuing financing activities 14.78%11.89M100.90%329K102.25%115K27,211.59%187.07M376,798.28%218.49M11,163.04%10.36M-13,181.88%-36.66M-1,042.63%-5.12M-100.32%-690K-100.05%-58K
Net issuance payments of debt ---73K--0--0-2,026.34%-40.51M--0--0-103,761.76%-35.31M-335.52%-5.2M1,540.41%2.1M22.73%-34K
Net common stock issuance --------------226.17M--216.2M--------------0--0
Proceeds from stock option exercised by employees -68.74%251K12,400.00%625K1,738.71%4.56M754.94%3.38M--2.32M421.43%803K--5K2.90%248K5.90%395K--0
Net other financing activities 81.20%-78K78.07%-296K-2,530.18%-4.45M38.21%-1.97M-50.00%-36K-1,496.15%-415K-457.85%-1.35M94.16%-169K-2,025.33%-3.19M-380.00%-24K
Cash from discontinued financing activities
Financing cash flow 14.78%11.89M100.90%329K102.25%115K27,211.59%187.07M376,798.28%218.49M11,163.04%10.36M-13,181.88%-36.66M-1,042.63%-5.12M-100.32%-690K-100.05%-58K
Net cash flow
Beginning cash position -34.94%90.92M156.02%271.16M193.80%281.41M-46.41%95.78M76.38%133.19M69.83%139.75M4.15%105.92M-46.41%95.78M296.69%178.74M-37.00%75.51M
Current changes in cash -66.70%-10.94M-632.76%-180.24M-201.16%-10.25M323.76%185.63M631.23%148.23M3.10%-6.56M274.29%33.83M113.15%10.13M-162.06%-82.96M-65.57%20.27M
End cash Position -39.95%79.98M-34.94%90.92M156.02%271.16M193.80%281.41M193.80%281.41M76.38%133.19M69.83%139.75M4.15%105.92M-46.41%95.78M-46.41%95.78M
Free cash flow -139.91%-40.6M-137.22%-21.08M-86.88%-32.37M97.61%-1.61M-82.13%-23.99M-18.07%-16.92M392.78%56.63M14.71%-17.32M-33.63%-67.16M20.97%-13.17M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.